Sai Life Sciences’ unlisted shares traded at Rs 577 on Tuesday in the grey market, indicating a 5.1% premium over the IPO price band’s upper limit of Rs 549.
So, on the downside, then we will again look at retesting 23,200, the lows that we made last month and if that breaks, then possibly
Amnish Aggarwal from Prabhudas Lilladher highlights the favorable position of power financiers in the renewable energy sector, despite high valuations post re-rating. He sees potential
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003